Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. , Int J Gynecol Cancer, 33(12):1906-1912: 2023

Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. , Int J Gynecol Cancer, ijgc-2023- 004805: 2023

Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. , Gynecol Oncol, 180:1-5: 2023

Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, F Simpkins, Kim SH “Utilization and outcomes of sentinel lymph node biopsy (SLNBX) for patients with cervical carcinoma; a multicenter database analysis” Focused ORAL Presentation , International Gynecologic Cancer Society Meeting, Seoul: 2023

Nasioudis D, Llaurado Fernandez M, Wong N, Powell D, Mills G, Westin S, Fader A, Carey M, Simpkins F The spectrum of MAPKERK pathway genomic alterations in gynecologic malignancies: opportunities for novel therapeutic approaches. , Gynecol Oncol, 177:86-94: 2023

Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Martin L, Simpkins F, Giuntoli R 2nd Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. , Gynecol Oncol, 177:14-19: 2023

Nasioudis D, Labban N, Latif NA, Gysler S, Cory L, Kim SH, Giuntoli RL 2nd, EM Ko Role of immunotherapy for lymph-node positive vulvar melanoma; utilization and outcomes. , Int J Gynecol Cancer, 33(9):1347-1353: 2023

Nasioudis D, George EM, Tanyi JL Controversies in the Staging of Patients with Locally Advanced Cervical Cancer , Diagnostics (Basel), 13: 2023,1747

D Nasioudis, S Gysler, NA Latif, EM Ko, L Cory, SH Kim, W Cliby, RL Giuntoli II “ Higher rates of neo-adjuvant chemotherapy use among high-risk patients with advanced stage epithelial ovarian carcinoma is associated with improved outcomes” POSTER, , 54th Annual Meeting of the Society of Gynecologic Oncology, Tampa: 2023

D Nasioudis, S Gysler, NA Latif, EM Ko, L Cory, SH Kim, RL Giuntoli II “Non-operative management of clinical early-stage endometrioid endometrial carcinoma: Hormonal or radiation therapy?” POSTER, , 54th Annual Meeting of the Society of Gynecologic Oncology, Tampa: 2023